- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00447408
Impact of a Personal Digital Assistant (PDA) - Based Dietary Adherence Intervention on Interdialytic Weight Gain and Blood Pressure in Hemodialysis Patients (BalanceWise-HD)
Impact of a PDA-Based Dietary Adherence Intervention on Interdialytic Weight Gain and Blood Pressure in Hemodialysis Patients
With this study the investigators will test, in a randomised clinical trial (RCT), the efficacy of a behavioral dietary adherence enhancement intervention paired with PDA-based dietary self-monitoring for controlling sodium intake. Seventy hemodialysis patients will be recruited from units in Pittsburgh, Pennsylvania. Participants will be randomized to a 4-month PDA-based dietary counseling intervention or to a 4-month attention control. Potential participants will be stratified by whether or not they have diabetes. Data on primary and secondary outcomes will be obtained at baseline and four months. Primary dependent variables are:
- adherence to dietary sodium targets as assessed from 3-day food recalls,
- average monthly interdialytic weight gain, and
- average pulse pressure. Secondary dependent variables are:
- adherence to dietary targets for calories, protein, carbohydrates, fats, saturated fats, potassium, and phosphorus, as assessed from 3-day food recalls, (5) serum potassium and phosphorus levels determined on a monthly basis, and (6) nutritional status as determined from serum albumin. Laboratory data, interdialytic weight gain, and blood pressure data will be obtained per dialysis center routine and abstracted from the medical record. Three-day food recalls will be obtained at baseline, 4 and 8 months and analyzed using the Nutrient Data System.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Those individuals who are 21 years of age or older
- Literate
- Community-dwelling adults
- Receiving maintenance HD for at least 3 months
Exclusion Criteria:
- Individuals who cannot read or write
- Those who do not speak English
- Those who plan to move out of the area or change dialysis centers within the next 6 months
- Those with a terminal illness and life expectancy of less than 12 months
- Those who are scheduled for a living donor transplant
- Individuals who cannot see the PDA screen or use the stylus to make selections from the PDA screen.
- Those individuals with a score ≤ 26 on the Mini Mental Status Exam.
- Also excluded will be individuals who are living in a nursing home or personal care facility, who would have limited control over their dietary intake.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: A
Education in the hemodialysis diet.
|
Participants receive standard hemodialysis dietary instruction via a PowerPoint presentation delivered during routinely scheduled dialysis treatments.
|
Experimental: B
Education in the hemodialysis diet.
Behavioral counseling paired with PDA-based self-monitoring of dietary sodium intake.
|
Participants receive standard hemodialysis dietary instruction via a PowerPoint presentation delivered during routinely scheduled dialysis treatments.
In addition they receive behavioral counseling paired with PDA-based self-monitoring of dietary sodium intake.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
adherence to dietary sodium targets as assessed from 3-day food recalls
Time Frame: baseline and 4 months
|
baseline and 4 months
|
average daily interdialytic weight gain (IDWG)
Time Frame: IDWG gathered with each dialysis treatment
|
IDWG gathered with each dialysis treatment
|
average pulse pressure from pre-dialysis blood pressures
Time Frame: with each dialysis treatment
|
with each dialysis treatment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
adherence to dietary targets for calories, protein, carbohydrates, fats, saturated fats, potassium, and phosphorus, as assessed from 3-day food recalls
Time Frame: collected at baseline and 4 months
|
collected at baseline and 4 months
|
serum potassium and phosphorus levels
Time Frame: baseline, and 1, 2, 3, and 4 months
|
baseline, and 1, 2, 3, and 4 months
|
nutritional status as determined from serum albumin
Time Frame: baseline, 1, 2, 3, and 4 months
|
baseline, 1, 2, 3, and 4 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mary A Sevick, ScD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0605006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End-Stage Renal Disease
-
Outset MedicalCompletedAcute Kidney Injury | End Stage Renal Disease (ESRD) | End Stage Renal Disease on DialysisUnited States
-
University of Illinois at ChicagoWithdrawnObesity | End-Stage Renal Disease | Renal Disease, End-Stage | Renal Failure, End-StageUnited States
-
Bioconnect Systems, IncCompletedEnd-stage Renal Disease | End-stage Kidney DiseaseUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...Changhai Hospital; Shanghai Zhongshan Hospital; RenJi Hospital; Ruijin Hospital; Shanghai... and other collaboratorsCompleted
-
Clinical Research Center for End Stage Renal Disease...Kyungpook National University Hospital; Medical Research Collaborating Center... and other collaboratorsActive, not recruitingEnd-Stage Renal DiseaseKorea, Republic of
-
Medtronic - MITGCompletedEnd-stage Renal DiseaseGermany
-
China Medical University HospitalUnknown
-
Guangdong Provincial Hospital of Traditional Chinese...Ministry of Science and Technology of the People´s Republic of ChinaUnknown
-
University of California, San FranciscoCompletedEnd-stage Renal DiseaseUnited States
-
Mark A. LumleyHenry Ford Health SystemCompleted
Clinical Trials on Standard hemodialysis dietary instruction
-
Henrik GudbergsenCharles University, Czech Republic; Region Capital DenmarkCompletedRheumatoid ArthritisDenmark
-
Shanghai Jiao Tong University School of MedicineBaxter Healthcare CorporationUnknown
-
National Institute of Diabetes and Digestive and...Washington University School of Medicine; University of Alabama at Birmingham; Icahn School of Medicine at Mount Sinai and other collaboratorsCompletedEnd Stage Renal DiseaseUnited States
-
Henning BliddalCambridge Weight Plan Limited; Velux Fonden; Oak Foundation; The Danish Rheumatism...CompletedObesity | Osteoarthritis, KneeDenmark
-
EXcorLab GmbHCompletedEnd-stage Renal DiseaseGermany
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
National Taiwan University HospitalUnknown
-
University of California, DavisCompletedCongestive Heart Failure | Cardiac Resynchronization TherapyUnited States
-
Texas Tech University Health Sciences CenterCompletedNutrition Disorders | Diet Modification | PCOS | MetabolismUnited States